Provell Pharmaceuticals

The Revolution in Drug Pricing: Provell Pharmaceuticals and Cost Plus Drugs Forge New Pathway for Affordable Medication

HONEY BROOK, PA — Provell Pharmaceuticals recently announced a partnership with Mark Cuban’s brainchild Cost Plus Drug Company, PBC (Cost Plus Drugs). They are set on bringing life-saving drugs to …

The Revolution in Drug Pricing: Provell Pharmaceuticals and Cost Plus Drugs Forge New Pathway for Affordable Medication Read More

Envestnet

Envestnet Emerges as Forefront Industry Leader in Advisor Software: Demystifying the Complexities of Investment Planning

BERWYN, PA — The investment market evolves continually, presenting intricate scenarios that challenge the knowledge and skills of financial advisors. In the rapidly advancing landscape of wealth management, the T3/Inside …

Envestnet Emerges as Forefront Industry Leader in Advisor Software: Demystifying the Complexities of Investment Planning Read More
Vishay Intertechnology

Vishay Intertechnology Boosts Infrared Transceiver Capabilities Amid Growing Demand for Wireless Data Transmission

MALVERN, PA — Vishay Intertechnology, Inc. (NYSE: VSH) has announced significant upgrades to its TFBS4xx and TFDU4xx series of infrared (IR) transceiver modules for IrDA® applications. The enhancements include a …

Vishay Intertechnology Boosts Infrared Transceiver Capabilities Amid Growing Demand for Wireless Data Transmission Read More
Ocugen

Ocugen’s Revolutionary Gene Therapy Targets Geographic Atrophy: A Shift in Ophthalmology on the Horizon

MALVERN, PA — Ophthalmology is on the crest of a wave; a paradigm shift heralded by Ocugen, Inc (NASDAQ: OCGN) may be imminent. The Pennsylvania-based biopharmaceutical firm recently crossed a …

Ocugen’s Revolutionary Gene Therapy Targets Geographic Atrophy: A Shift in Ophthalmology on the Horizon Read More